Repare Therapeutics’ RPTX shares jumped 13.9% on Jun 5 after the FDA granted the Fast Track designation to its investigational combination therapy of lunresertib and camonsertib to treat adult ...
Adicet Bio ACET gained 9.4% on Jul 8 and continued to gain another 2.6% during the after-market hours after the FDA granted Fast Track designation to its investigational candidate, ADI-270, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results